Press Release: Virta : Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained Weight Loss

DENVER--(BUSINESS WIRE)--Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the company's approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic. Published today in Diabetes Therapy, the data demonstrates Virta is a powerful and sustainable off-ramp from GLP-1s. These outcomes stand in stark contrast to other real-world results of GLP-1 weight loss t